BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24608673)

  • 1. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
    Gang C; Qiang C; Xiangli C; Shifen P; Chong S; Lihong L
    J Pharm Pharm Sci; 2015; 18(2):235-48. PubMed ID: 26158288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
    Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE
    J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
    Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
    Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.
    Yu X; Jia B; Wang F; Lv X; Peng X; Wang Y; Li H; Wang Y; Lu D; Wang H
    J Cell Mol Med; 2014 Feb; 18(2):263-73. PubMed ID: 24304472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.
    Sano M; Fukuda K; Sato T; Kawaguchi H; Suematsu M; Matsuda S; Koyasu S; Matsui H; Yamauchi-Takihara K; Harada M; Saito Y; Ogawa S
    Circ Res; 2001 Oct; 89(8):661-9. PubMed ID: 11597988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K/AKT pathway.
    Cheng Y; Shen A; Wu X; Shen Z; Chen X; Li J; Liu L; Lin X; Wu M; Chen Y; Chu J; Peng J
    Biomed Pharmacother; 2021 Jan; 133():111022. PubMed ID: 33378940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
    Wang S; Han HM; Pan ZW; Hang PZ; Sun LH; Jiang YN; Song HX; Du ZM; Liu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):823-31. PubMed ID: 22569796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy.
    Wu QQ; Zong J; Gao L; Dai J; Yang Z; Xu M; Fang Y; Ma ZG; Tang QZ
    Herz; 2014 May; 39(3):390-6. PubMed ID: 23784363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species.
    Takahashi M; Suzuki E; Takeda R; Oba S; Nishimatsu H; Kimura K; Nagano T; Nagai R; Hirata Y
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2879-88. PubMed ID: 18441197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
    Meijles DN; Cull JJ; Markou T; Cooper STE; Haines ZHR; Fuller SJ; O'Gara P; Sheppard MN; Harding SE; Sugden PH; Clerk A
    Hypertension; 2020 Oct; 76(4):1208-1218. PubMed ID: 32903101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
    Yu L; She T; Li M; Shi C; Han L; Cheng M
    Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.
    Shen DF; Tang QZ; Yan L; Zhang Y; Zhu LH; Wang L; Liu C; Bian ZY; Li H
    Br J Pharmacol; 2010 Feb; 159(4):970-81. PubMed ID: 20105174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-κB signal pathway in hepatocytes.
    Zhao J; Liu J; Pang X; Wang S; Wu D; Zhang X; Feng L
    Cell Physiol Biochem; 2013; 32(3):569-80. PubMed ID: 24021937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.